Skip to main content

Patent Ductus Arteriosus in Premature Infants: Clinical Trials and Equipoise

Our Presenters Include:

DATE:
Wednesday, June 16, 2021
PURPOSE:
To identify best practices to achieve equipoise in PDA clinical trials.
OBJECTIVES:
Work towards a large consortium to trial of PDA questions
Identify the different obstacles to pragmatic trials and propose solutions to guide trial design
Provide thought leadership on how to navigate ongoing shifts in clinicians’ understanding and approach to PDA
RECORDED PRESENTATIONS:
Follow this link to prerecorded symposium presentations.
CME STATEMENT:
Accreditation Statement: The School of Medicine of the University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement: The School of Medicine of the University of North Carolina at Chapel Hill designates this live internet course for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: This activity has been planned and implemented under the sole supervision of the Course Director, Matthew Laughon, MD, MPH, in association with the UNC Office of Continuing Professional Development (CPD). Dr. Laughon received consulting fees from Bayer (ended Jan 2021) and United Therapeutics (ended Nov 2019) but has no current relevant financial relationships with ineligible companies as defined by the ACCME. The presenters and CPD staff have no relevant financial relationships with ineligible companies.

QUESTIONS:
For inquiries regarding this symposium, please contact Laurie Stockton at laurie_stockton@med.unc.edu.